Recent study on drug for newly diagnosed glioblastoma patients

submitted by: mdanderson

Bevacizumab offers no benefit for newly diagnosed glioblastoma (brain) cancer patients, MD Anderson-led study finds. Mark Gilbert, M.D., professor in Neuro-Oncology at MD Anderson Cancer Center, and Minesh Mehta, M.D., Ph.D., chairman of Radiation Oncology at the University of Maryland School of Medicine, discuss their study in the front line setting for the treatment of glioblastoma.

One Meeting of the PACT activity

submitted by: zy05280

Many thanks to all your you~

PACT Activity

submitted by: zy05280

Passport to Autonomy in Collaboration with Tutors

Study Shows Importance of Proton Therapy for Childhood Cancer

submitted by: mdanderson

Dr. David Grosshans discusses a recent study that shows how proton therapy spares healthy tissue in children with cancer. The study illustrates how proton therapy radiation is able to avoid excess radiation dose to a variety of normal structures while maintaining equal target coverage. This is important for childhood cancers because excess radiation can cause damage to the hippocampus, an area involved in learning and memory.

Saving Young Lives in Zambia

submitted by: busph
Anti-malarial drugs are being used inappropriately for sick children in Zambia -- a problem that can be addressed by arming community health workers with a simple rapid-diagnostic test and a supply of antibiotics, a study led by researchers at Boston University School of Public Health has found. Listen to Kojo Yeboah-Antwi, assistant professor of international health at BUSPH, and David Hamer, professor of international health at BUSPH, discuss the study. Learn more at...

America's Climate Choices

submitted by: earthandlifescience
In a new video from the National Academies, experts serving on the America's Climate Choices study committee and panels talk about the project, which aims to inform and guide the nation's response to climate change. The video takes an in-depth look at the process through which these experts will come to consensus, and highlights how crucial the choices we face now will be for decades to come. Congressman Alan Mollohan (D-WV) provides his perspective as the initiator of the project. The...

Epigenomics of Cancer - Prof. Wei Li (Part 1, 2009)

submitted by: ralanharris

Prof. Wei Li lectures on studies of transcription factor binding sites and histone modifications using ChIP-chip and Chip-seq assays. Part of the Computer Aided Discovery Methods 2009 course offered at Baylor College of Medicine.